Scout

The SBIR/STTR reauthorization just passed the Senate. That alone is significant. But what matters more is what happens next. Earlier, the Senate unanimously passed S.3971, the bipartisan bill to reauthorize the SBIR and STTR programs. During the Senate discussion, lawmakers referenced reopening the program immediately and encouraging agencies to move quickly. If the remaining steps move forward in the House and the bill is signed, we may see the innovation pipeline reopen rapidly. That means the next few months could be a very active period for the SBIR ecosystem. However when solicitations reopen, the timeline between topic release and submission deadlines is often tight. The teams that move first will likely be the ones already doing the work now. In other words, grant readiness may matter more than ever this year.

Energy tech founders — this is a fantastic opportunity to kickstart your company with an amazing partner.

After +10 yrs advising 100s of startups on their non-dilutive funding strategies, I wondered why some of the most innovative tech never got off the ground. I thought it was the market, the pitch, the founder. But, I was wrong. The facts were ugly: - Only ~23% of university-licensed startups (especially in life sciences) ever achieve meaningful economic success - Slow IP licensing and bureaucratic hurdles can kill momentum - 1 survey noted 66% of spinout founders cannot leave their academic positions to start the company - Technology-first startups often lack market pull where many academic spinouts originate from novel research rather than customer pain-points - University tenure and promotion criteria rarely reward entrepreneurship I've been there and I get it. Scaling this kind of infrastructure and support to accelerate the rates of university spin-outs is difficult. But my curiosity has now taken a turn. Can Scout help with the gap? I'm looking for insights to help me better understand: - Where does the system break down? - Why is this still so hard? - What are we missing? If you are building startup ecosystems, venture studios, or working in tech transfer, I need your perspective. Give me your take in the comments below & let's chat.

Our thoughts and prayers go out to the community at Brown University.

Scout is proud to be a sponsor of this year's Yale Ventures life sciences Pitchfest event. It is incredibly exciting to see the incredible innovation happening within the ecosystem between the faculty and spin-outs. Are you working in healthcare or biotech? Be sure to register and attend this Thursday in New Haven!

I’m honestly frustrated for biotech start-ups who keep missing moments like this. ARPA-H has three MASSIVE $$ opportunities out. No one’s talking about them. Let's find out whether your tech qualifies... 💢 GIVE — Genetic Medicines & Individualized Manufacturing 👉 ARPA-H wants... Breakthrough platforms that enable distributed, low-cost, automated RNA and genetic medicine manufacturing instead of today’s centralized, expensive, bottlenecked systems. Radically new manufacturing technologies, automation systems, and QC platforms that make personalized genetic therapies scalable and widely accessible. 👉 Solution Summary Deadline : Dec 19, 2025 👉 Full Proposal Due: Feb 27, 2026 💢 AIR — Autonomous Interventions & Robotics 👉 ARPA-H wants... Autonomous and semi-autonomous robotic systems capable of performing time-critical surgical interventions (e.g., stroke thrombectomy) anywhere, not just in specialized hospitals. B old advances in robotics, micro-bots, imaging, sensing, and AI-guided procedural autonomy that can deliver high-acuity care with minimal expert oversight. 👉 Solution Summary: Jan 26, 2026 👉 Full Proposal Due: March 30, 2026 💢 MOCS — Making Obstetric Care Smart 👉 ARPA-H wants... Innovations that transform labor and delivery monitoring using next-gen, non-invasive, AI-driven diagnostic tools to reduce maternal and neonatal morbidity. Novel biosensors, real-time fetal oxygenation metrics, placenta-risk diagnostics, and decision-support systems that deliver trustworthy data during pregnancy and birth. 👉 Pre-proposal meetings: Dec 15–19, 2025 👉 Full Proposal Due: Jan 21, 2026 Please help me get this in front of the teams who shouldn’t miss this. Tag a biotech founder who needs to see these ARPA-H programs before these windows close. Details for each opportunity are in the comments below.

Moments like this separate rushed applicants from prepared ones. At Scout, we’re still backing a limited number of teams across NIH SBIR/STTRs, contracts, R01s, R21s, and others. If you’re navigating this too, let’s connect and build a smart plan around it.

Calling all AgTech Founders!! Grants are available for your start-up w/ extended deadlines into 2025. You don't want to miss out!

Founders! Are you attending NNEMTC next week? If so, don't forget to snag a pro-bono 1:1 consultation session with our co-founder, Stacy Chin, to chat through your SBIR/STTR & non-dilutive fundraising strategy (limited spots available!

Did you know Scout has a YouTube Channel? We’re sharing real stories, funding hacks, and behind-the-scenes looks at how startups win non-dilutive capital. Link in the description and don't forget to like & subscribe!